Reddit Posts
22 OCT 2026 , WHAT ARE THE BIGGEST LOSERS AND WHY ?
Undervalued Stocks Under $5
5 Deep-Value Stocks Under $5 π
Diamond in the rough MDXG. YOLO in for the long haul. Woefully undervalued considering current BUSINESS is SOLIDπ with projected annual revenue growth of 11% to 14% and a biotech pipeline with πππBLOCKBUSTER potential.
Mimedx MDXG Hitting 52 Wk Highs on Disruptive Innovation in Wound Healing & Blockbuster Pipeline
$MDXG π₯ Game Changing Regenerative Medicine Company Joins the Russell Index πππ
MDXG...is anybody watching this goodness? Retraced on light volume to Friday's swing low and just bucked the trend the rest of the day. That's relative strength!
Mimedx (MDXG) and Tilray (TLRY) tendies = my dream car 2020 GT350 Mustang Shelby Cobra. π
$MDXG - Management Miscommunication Skews Valuation Down and Creates Great Buying Opportunity
My Watchlist for 4/29/2021 -- Anti-Hype List As Always
Great Regenerative Medicine Earnings Play/Investment Opportunity! Mimedx (MDXG)
Mentions
PRSO- is only making up once after a month INO - this doesn't above the 0.91 MDXG- n October 15, the company issued a preliminary Q3 2026 revenue update and suspended its full-year 2026 revenue guidance of $110β115 million. Management attributed the shortfall to unexpected sales-force turnover after discontinuing Resolve mdx. HELL NO look for something else the someone wants to go to zero lol
PRSO getting wrecked after a rally is classic, the volume spike probably pulled in a bunch of chasers who are now panic-selling. Seen that play out a hundred times. INO's been circling the drain for a while, every time I check their cash runway it's shorter and the dilution gets uglier. Not touching that one. MDXG is the only ticker here I'd actually look at for a reversal play, healthcare stocks sometimes bounce hard after these earnings dips. The rest feel like falling knives.
What the Hell, I can afford to take my MDXG money and treat myself. 900 shares
Still rising slowly: SLS. Holding this one for a bit to see how their cancer drug turns out. Not so much/what was I thinking: STSS, TGEN, NWTN, MDXG
$MDXG 2008. Fell from $4 to 50 cents. Then bounced to $17. $AXGN took even longer but hit $65. $CLDX, $OPHT->$ISEE Dozens of them over the years, but I know what I am buying. Before I but it. And I double down/manage the costs. If you are buying a stock you found on social media or reddit most likely you got pulled into a pump and dump.
I'm of the opinion that the content of the argument and investment thesis is much more important than the position size or current gain/loss. That stuff doesn't matter to me. It's a red herring that other people use to jump on a bandwagon and baghold a diamond hand FOMO position. FFIE being a prime example of that. That being said, the content of OPs thesis is kind of shit. I'm looking at another potential long position on it, but that's because of the Cohodes supercult having an innate ability to turn a profit into a loss. Because they never cover and want all the stocks they hate on to go to zero, which they never do. So they will eventually be squeezed like they were on HCG and MDXG.
I bought NVDA because of gaming for $59 in 2017. Still hold most of it Bought a curious medical stock called mimedix many years ago. MDXG. I bought a little at a time for $1-1.25/share. Eventually I had $25k worth. Then they went up to about $14. I sold all but about $5k. This gave me money to buy other great stocks. Still have it but in the mean time it went back down to $1 but now is at about $7. I think it will go up a lot more eventually...
BBAI and MDXG need to move up or all I got are stinkers.
Saw some guys post about how MDXG was going to gain. I blindly followed because calls were dirt cheap. Lottery ticket method.
So why not short MDXG? Since the stock can only go down from here, take a big short position in it - the post is definitely fishy!
Patience my boy. It can be challenging but one can make money on biotech. Buy low, wait through DOWNS and hope for the drug to work in time for the patents to still be in place when the big pharma company buys them. When it goes up SELL a good portion. Don't bet the farm but small bets can pay off. My best is when MDXG was $1.25 for 3 or 4 years before they shot to 16! I sold about $200k on that before that went back down to $2. They stayed there for another 2 y or so and now are up to $7. I bought EXEL about 6 yrs ago and just stays in a narrow range. Maybe someday... Don't pick em yourself. Use technical sources on the credibility of the drugs action and chances of success
I am a bot. You submitted a picture of a banned ticker, MDXG. The market cap of MDXG is **354,644,700** This check will fire if you included unnecessary pictures that have bad keywords/phrases. Repost with the useless pictures omitted if you did that.
I am a bot. You submitted a picture of a banned ticker, MDXG. The market cap of MDXG is **354,644,700** This check will fire if you included unnecessary pictures that have bad keywords/phrases. Repost with the useless pictures omitted if you did that.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: MDXG. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.
But which one ?? All of them ?? MDXG??
MDXG gave me a heart attack today when it failed its trials. Think I might sit out of biotech for a bit.
F for everyone in MDXG. [Trials did not pan out.](https://www.streetinsider.com/Corporate+News/MiMedx+Group+%28MDXG%29+Announces+Two+Trials+with+Proprietary+Amniotic+Tissue+Technology+Did+Not+Meet+Primary+Endpoints/18930016.html) Such is biotech.
MDXG - Phase IIB (Knee Osteoarthritis) and Phase III (Plantar fasciitis) data for Amniofix Injectable due any time within the next two weeks.
Wow, what a coincidence. PSFE and my biggest holding, MDXG, both finished the day yesterday at $11.11. This could be an omen.
14 Mimedx MDXG 9/17/21 Calls $10 Strike @ $2.20 or 2 Exact Sciences EXAS 1/21/22 Calls $130 Strike @ 14.50. Or better yet, half and half. I am Uber long both contracts. Great companies with a lot of near term catalysts. Good luck!
Very long Mimedx (MDXG) - micronized amnion/chorion treatment for knee osteoarthritis in clinical trials and Exact Sciences (EXAS) - developing blood based multi-cancer screening test.
Mimedx MDXG - best in class advanced wound care products derived from amniotic tissue for the treatment of diabetic foot ulcers. Also a very promising pipeline of micronized injectable amniotic tissue (Amniofix Injectable) for the treatment of knee osteoarthritis and other musculoskeletal conditions. Amarin - Vascepa (icosapent ethyl) derived from fish oil for the treatment of high triglycerides and for the reduction of cardiovascular events in high risk patients.
Good luck. SEC has never reigned in naked shorts and never will. Ask $MDXG
Turnaround play here in MDXG - under-the-radar company with potential to double or even triple from here. H.C. Wainwright just initiated coverage of the company with a $20 price target. It currently trades around $10 a share. Here's a link to the research report - [https://filebin.net/bg8d7pkuy75dl05k](https://filebin.net/bg8d7pkuy75dl05k)
Interesting analysis from hedge fund Prescience Point on Mimedx $MDXG https://twitter.com/PresciencePoint/status/1372538867631411205?s=20
Adding to my Mimedx position (MDXG) which reports earnings tomorrow after market close. Great value which could easily triple in the next six months. Check out Prescience Point research report.
The largest holding in my portfolio currently is Mimedx (MDXG), which is a turnaround play with a very promising regenerative medicine pipeline. Their micronized injectable amniotic tissue product, Amniofix Injectable, is in clinical trials for a number of musculoskeletal indications including plantar fasciitis, knee osteoarthritis and achilles tendinitis. Mimedx has held up extremely well relatively speaking given recent market volatility. I added on the dip Friday below $10. Earnings announcement Monday after the bell with clinical trial readouts expected this Spring. Regardless of what is happening with the economy, I believe Mimedx and other health care companies which serve an aging population will thrive, making this a good defensive pick in my opinion in this uncertain market environment. Another competitor in this same space, Organogenesis, has been on a tear lately. With elective medical procedures back on the upswing, these are reopening trades as well. Hedge fund Prescience Point has done some compelling research on this name with a $31 price target. Definitely a research report worth reading. Due your own due diligence. Cheers! [Prescience Point Mimedx Research](https://www.presciencepoint.com/research/research-archives/mimedx-group-inc-mdxg-update/)
Mimedx (MDXG) earnings Monday March 8th after the bell with conference call Tuesday March 9 at 9:30 a.m. Eastern time. Regenerative medicine/reopening play.
The largest holding in my portfolio currently is Mimedx (MDXG), which is a turnaround play with a very promising regenerative medicine pipeline. Their micronized injectable amniotic tissue product, Amniofix Injectable, is in clinical trials for a number of musculoskeletal indications including plantar fasciitis, knee osteoarthritis and achilles tendinitis. Mimedx has held up extremely well relatively speaking given recent market volatility. I added on the dip Friday below $10. Earnings announcement Monday after the bell with clinical trial readouts expected this Spring. Regardless of what is happening with the economy, I believe Mimedx and other health care companies which serve an aging population will thrive, making this a good defensive pick in my opinion in this uncertain market environment. Another competitor in this same space, Organogenesis, has been on a tear lately. With elective medical procedures back on the upswing, these are reopening trades as well. Hedge fund Prescience Point has done some compelling research on this name with a $31 price target. Definitely a research report worth reading. Due your own due diligence. Cheers! [Prescience Point Mimedx Research](https://www.presciencepoint.com/research/research-archives/mimedx-group-inc-mdxg-update/)
WARNING: NOT A MEME STOCK MDXG.. don't you dare fucking pump this stock and ruin it. But if you want something safe just check out it's chart and hold. It's been consistent even when the market sucks. And it'll continue being consistent if you vultures don't fuck it up. Lol. As for meme stocks it's easy. Pick the top 5 newest meme stocks and buy a call expiring that week. One of them will go up and make you more money than you lost on all the others. Rinse and repeat for each new fad.
$MDXG Recently relisted (and undervalued) Wound Care company shifting to Theraputic Biologics based on Placental stem cells with a Phase 3 trial for Plantar Fasciitis ending soon (with very good chances of positive results). They have a Knee Osteoarthritis product in Phase 2B which will send this thing to the moon or get it acquired with good data. If the Plantar Fasciitis trial goes well itβs a very good indicator for the Knee Osteoarthritis trial to go well which is a $3 to 6B/year product for a company currently valued under 1.3B. Currently the company is barely fairly valued for its Wound Care line and completely undervalued for what will be a huge market opportunity with the PF and Knee OA products. Iβve posted about this before when it was 6.66 and it just hit $11. Iβm planning for it to hit at minimum $50 but truly targeting $100+ next few years if PF/Knee OA goes well.
MDXG defying gravity today and it's leaps are absolutely dirt cheap.
You mother fuckers. I finally got out of all my meme stocks. Had all my calls in shit that's safe and boring. QQQJ leaps. Globalstar leaps. MDXG leaps. I finally had no stress if some meme stock was going to take off. And then you shit heads had to pump RKT until I finally FOMO'D into $32C 3/19. There's no fucking way it's getting there. But you retards have made dumber stuff happen so now I gotta throw $50 just in case. RKT to the moon I guess.